OECD Home › Science and technology › Publications & Documents
Publications & Documents
English, , 442kb
Trust among the users of ICT networks is an increasing priority for business, industry and governments. This report reviews data available from official, semi-official and private sources which can assist in informing developments and progress in this area.
With case studies on Austria, Belgium (Flanders), Finland, Greece, Ireland, the Netherlands, Norway and Sweden, this book illustrates mechanisms and practices for better governance co-ordination and integration across policy areas.
OECD economic globalisation indicators help identify the economic activities of member countries under foreign control, and more particularly the contribution of multinational enterprises to growth, employment, productivity, labour compensation, R&D, technology diffusion and int trade.
The initiative for this workshop grew from an idea launched by France’s Mission for Gender Equality in Research and Higher Education, following a conference bringing together OECD Ministers of Research in January 2004.
This book presents case studies on innovation policy governance in Australia, Austria, Belgium (Flanders), Finland, Greece, Ireland, Japan, Korea, Netherlands, New Zealand, Norway and Sweden. It provides fresh insight into how governments are striving to make innovation policy more coherent.
In order to foster innovation in their countries, governments first need to be able to measure it. But what means do they have at their disposal? The Oslo Manual provides them with the essential methodological guidelines.
English, , 176kb
Scoreboard 2005 Executive Summary Greece
While many countries have invested in the production of health technology assessment, evidence about its use in decision making is limited. This report analyses the barriers to, and facilitators of, evidence-based decision making in OECD health-care systems.
This workshop brought together a wide range of stakeholders, including officials of regulatory agencies, representatives of relevant regional or international organizations, researchers, patients’ organizations and representative from industry.